Javier Martin-Broto

56PUBLICATIONS
272CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursComparative language studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Aug 02, 2026
Biomarkers of prognosis and pazopanib response in soft tissue sarcoma: An exploratory analysis.

|Jul 30, 2026
Feasibility and activity of concurrent neoadjuvant chemotherapy and radiation therapy in patients with high-risk soft tissue sarcoma.

|Jul 20, 2026
TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors.

|Jun 10, 2026
Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

|Mar 16, 2026
IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort.

Javier Martin-Broto, Sandra J Strauss, Emanuela Palmerini

|Mar 12, 2026
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma.

Javier Martin-Broto, Javier Martinez-Trufero, Roberto Diaz-Beveridge

Pageof 10

Frequent Collaborators

18 joint publications

Nadia Hindi

16 joint publications

David S Moura

11 joint publications

Jean-Yves Blay

9 joint publications

Emanuela Palmerini